06/25/2025
7:46 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/18/2025
3:30 PM | Carson Lisa Cabott (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/12/2025
6:49 AM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2025
3:59 PM | Ferrara Robert L (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
4:00 PM | Bitterman Robert J (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2025
3:43 PM | Bitterman Robert J (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
8:04 AM | Bitterman Robert J (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2025
7:20 AM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/31/2025
3:42 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/20/2025
2:02 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2025
3:09 PM | CVI Investments, Inc. (Filed by)
Phio Pharmaceuticals Corp. (Subject)
Phio Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
Get the Latest News and Ratings for PHIO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Phio Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
01/28/2025
11:15 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form EFFECT | |
01/28/2025
3:16 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
01/23/2025
2:45 PM | Orca Capital AG (Filed by)
Phio Pharmaceuticals Corp. (Subject)
Phio Pharmaceuticals (Subject)
| Form SCHEDULE 13G | |
01/21/2025
3:39 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
01/17/2025
3:44 PM | INTRACOASTAL CAPITAL, LLC (Filed by)
Phio Pharmaceuticals Corp. (Subject)
Phio Pharmaceuticals (Subject)
| Form SCHEDULE 13G | |
01/17/2025
7:00 AM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 424B5 | |
01/15/2025
7:00 AM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 424B5 | |
01/14/2025
4:18 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/14/2025
12:34 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 424B5 | |
01/13/2025
9:55 AM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/07/2025
3:06 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
12/27/2024
4:05 PM | INTRACOASTAL CAPITAL, LLC (Filed by)
Phio Pharmaceuticals Corp. (Subject)
Phio Pharmaceuticals (Subject)
| Form SCHEDULE 13G | |
12/26/2024
1:19 PM | CVI Investments, Inc. (Filed by)
Phio Pharmaceuticals Corp. (Subject)
Phio Pharmaceuticals (Subject)
| Form SCHEDULE 13G | |
12/23/2024
3:05 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 424B5 | |
12/20/2024
7:00 AM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 424B5 | |
12/19/2024
7:38 AM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
10:20 AM | INTRACOASTAL CAPITAL, LLC (Filed by)
Phio Pharmaceuticals Corp. (Subject)
Phio Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/07/2024
9:21 AM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/13/2024
1:59 PM | Bitterman Robert J (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
1:59 PM | Freeman Jonathan E (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
2:00 PM | Infarinato Robert M. (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
3:10 PM | BRADFORD PATRICIA A (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
3:11 PM | Ferrara Robert L (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
3:11 PM | Lockshin Curtis (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2024
3:14 PM | Infarinato Robert M. (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
3:45 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/09/2024
8:05 AM | Infarinato Robert M. (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/05/2024
7:00 AM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 424B3 | |
08/01/2024
11:15 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form EFFECT | |
08/01/2024
7:00 AM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
The $7 company helping Nvidia build the world’s first trillion-dollar robot … (Ad) Michael Robinson has been at the forefront of the technology market for over 40 years.
Spotting some profitable trends in tech … well ahead of Wall Street.
Like when he called Nvidia at a mere 80 cents a share.
Or Bitcoin when it was trading for just $300.
Throughout his illustrious career …
Michael has given his followers almost 150 different chances to register triple-digit gains. Now he's identified his next potential winner. Click here to find out more. |
07/26/2024
3:30 PM | Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
